Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Fennec Pharmaceuticals (FENC) Shares Issued (2016 - 2025)

Fennec Pharmaceuticals filings provide 11 years of Shares Issued readings, the most recent being $40.1 million for Q4 2025.

  • On a quarterly basis, Shares Issued rose 4926.85% to $40.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.0 million, a 3132.05% increase, with the full-year FY2025 number at $42.0 million, up 3132.05% from a year prior.
  • Shares Issued hit $40.1 million in Q4 2025 for Fennec Pharmaceuticals, up from $1.8 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $40.1 million in Q4 2025 to a low of -$470000.0 in Q3 2024.
  • Median Shares Issued over the past 4 years was $359000.0 (2024), compared with a mean of $2.9 million.
  • Biggest five-year swings in Shares Issued: crashed 318.6% in 2024 and later surged 4926.85% in 2025.
  • Fennec Pharmaceuticals' Shares Issued stood at $679000.0 in 2022, then rose by 10.01% to $747000.0 in 2023, then increased by 6.69% to $797000.0 in 2024, then surged by 4926.85% to $40.1 million in 2025.
  • The last three reported values for Shares Issued were $40.1 million (Q4 2025), $1.8 million (Q3 2025), and -$185000.0 (Q2 2025) per Business Quant data.